Description

Specifications

• Form: White lyophilized powder
• Standard vial size: research-grade, typically supplied in mg quantities
• Purity: ≥99% (HPLC & Mass Spec verified)
• Sequence: Tripeptide, Ala-Glu-Asp (cartilage-tissue-selective bioregulator)
• Storage: Store lyophilized powder at -20°C; refrigerate at 2–8°C once reconstituted

Overview

Cartalax is a synthetic bioregulator peptide studied for proposed selectivity toward cartilage and connective tissue, extending the bioregulator peptide research family into musculoskeletal research applications.

Mechanism & Research Findings

Preclinical research on Cartalax has examined its effects on chondrocyte gene expression and cartilage matrix protein synthesis in models of cartilage degeneration, consistent with the tissue-selectivity hypothesis underlying this entire bioregulator peptide class. It is studied as a tool compound for researchers investigating chondrocyte biology and age-related cartilage-matrix decline.

Research Applications

• Chondrocyte gene-expression research
• Cartilage matrix protein-synthesis studies
• Age-related joint-tissue degeneration models

For laboratory research use only. Not for human consumption, diagnostic, or therapeutic use.